Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.32 CHF | +1.97% | +4.94% | +8.78% |
05:13pm | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
03:43pm | Novartis Gets FDA Breakthrough Therapy Designation for Scemblix | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.78% | 204B | |
+30.66% | 695B | |
+26.51% | 568B | |
-4.61% | 361B | |
+19.69% | 330B | |
+3.82% | 283B | |
+16.70% | 239B | |
-7.93% | 198B | |
+8.08% | 168B | |
+5.09% | 125B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis Scraps Late-Stage NIS793 Trial on Benefit-Risk Assessment